# Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue

> **NCT05428527** · — · COMPLETED · sponsor: **National Defense Medical Center, Taiwan** · enrollment: 261 (actual)

## Conditions studied

- Cancer-related Fatigue

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05428527
- **Lead sponsor:** National Defense Medical Center, Taiwan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-08
- **Primary completion:** 2023-12-28
- **Final completion:** 2023-12-31
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05428527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05428527, "Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05428527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*